- Home
- VRDN vs AVNS Comparison
VRDN vs AVNS Comparison
Compare VRDN & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRDN | AVNS |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | VRDN | AVNS |
|---|---|---|
| Price | $16.14 | $24.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $35.46 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 1.2M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.59 |
| EPS | N/A | ★ 0.11 |
| Revenue | $5,706,000.00 | ★ $701,200,000.00 |
| Revenue This Year | $13.73 | $3.28 |
| Revenue Next Year | $279.00 | $4.23 |
| P/E Ratio | ★ N/A | $227.09 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $13.18 | $9.30 |
| 52 Week High | $34.29 | $25.49 |
Technical Indicators
Market Signals| Indicator | VRDN | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 46.86 | 76.95 |
| Support Level | $15.65 | $24.60 |
| Resistance Level | $18.05 | $25.49 |
| Average True Range (ATR) | 0.81 | 0.12 |
| MACD | -0.06 | -0.17 |
| Stochastic Oscillator | 24.81 | 46.28 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.